Through in vitro studies, the authors demonstrated the specific cytotoxicity of CD1a CAR-T cells against CD1a+ T-ALL cell lines and primary blasts, while studies on a patient-derived xenograft model of cortical coT-ALL confirmed their potent anti-leukemic activity. This evidence concerns the gene CD1A and acute lymphoblastic leukemia.